SEPSIS PATOGENEZIDA MIKROORGANIZMLAR, IMMUN TIZIM VA GEMATOLOGIK KO‘RSATKICHLARNING O‘ZARO BOG‘LIQLIGI: ZAMONAVIY DIAGNOSTIK YONDASHUVLAR

Authors

  • Alikulova D.Y. Toshkent davlat tibbiyot universiteti, Allergologiya,klinik immunologiya va hamshiralik ishi kafedrasi katta o’qituvchisi, PhD
  • Hamdamov A.I. Toshkent davlat tibbiyot universiteti, 2-son davolash fakulteti talabasi
  • Ernazarova M.I. Toshkent davlat tibbiyot universiteti, Menejment,fundamental tibbiyot , biotibbiyot muhandisi va OMH fakulteti talabasi

Keywords:

sepsis, septik shok, mikroorganizmlar, PAMP, DAMP, immun javob, tug‘ma immunitet, sitokinlar, neytrofillar, limfotsitlar, trombotsitlar, NETs, immunotromboz, DVS-sindrom, prokaltsitonin, C-reaktiv oqsil, laktat, NLR, PLR, SOFA, qSOFA, molekulyar diagnostika

Abstract

Sepsis — infeksiyaga nisbatan organizmning disregulyatsiyalangan javobi natijasida rivojlanadigan, hayot uchun xavfli organ disfunksiyasi bilan kechuvchi murakkab patologik sindromdir. Uning patogenezida mikroorganizmlarning virulentlik omillari, patogen bilan bog‘liq molekulyar naqshlar (PAMP), zararlangan hujayralardan ajraladigan molekulalar (DAMP), tug‘ma va adaptiv immun tizim, endoteliy, trombotsitlar, koagulyatsiya tizimi hamda mikrosirkulyatsiya o‘rtasidagi murakkab o‘zaro ta’sirlar muhim ahamiyatga ega. Sepsis faqatgina kuchli yallig‘lanish holati emas, balki proinflammator va immunosupressiv mexanizmlarning bir vaqtda kechishi, endotelial disfunksiya, immunotromboz, metabolik buzilishlar va organlar faoliyatining izdan chiqishi bilan tavsiflanadi. Zamonaviy qarashlarga ko‘ra, bakterial lipopolisaxarid, peptidoglikan, lipoteixoy kislotalar, flagellin va boshqa mikrob komponentlari Toll-like retseptorlar hamda boshqa pattern-recognition receptorlar orqali immun javobni faollashtiradi. Natijada TNF-α, IL-1β, IL-6, interferonlar, komplement komponentlari va boshqa mediatorlar ajralishi kuchayadi. Shu bilan birga, neytrofillarning faollashuvi, NETs hosil bo‘lishi, trombotsitlar agregatsiyasi va to‘qima omilining faollashishi mikrotromboz va koagulyatsion buzilishlarni yuzaga keltiradi. Gematologik ko‘rsatkichlardan leykotsitoz yoki leykopeniya, neytrofiliya, limfopeniya, trombotsitopeniya, neytrofil-limfotsit nisbati (NLR), trombotsit-limfotsit nisbati (PLR) va boshqa ko‘rsatkichlar sepsisni baholashda qo‘shimcha ma’lumot berishi mumkin. Zamonaviy diagnostik yondashuvlar klinik baholash, SOFA, qSOFA, laktat, qon ekmalari, prokaltsitonin, C-reaktiv oqsil, molekulyar mikrobiologik usullar va immunologik biomarkerlarni kompleks baholashga asoslanadi.

References

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287.

Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of Clinical Criteria for Sepsis. JAMA. 2016;315(8):762-774. doi:10.1001/jama.2016.0288.

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock. JAMA. 2016;315(8):775-787. doi:10.1001/jama.2016.0289.

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med. 2021;47(11):1181-1247. doi:10.1007/s00134-021-06506-y.

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):1974-1982.

van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:1-14.

Deutschman CS, Tracey KJ. Sepsis: Current dogma and new perspectives. Immunol Rev. 2014;263(1):40-47.

Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.

Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14:417-427.

Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol. 2008;83(3):536-545.

Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38-44.

Delabranche X, Quenot JP, Lavigne T, Mercier E, Francois B, Severac F, et al. Early detection of disseminated intravascular coagulation during septic shock. Crit Care. 2016;20:5.

Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019;7:2050312119835043.

Font MD, Thyagarajan B, Khanna AK. Sepsis and septic shock – basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020;104(4):573-585.

Rhee C, Kadri SS, Danner RL, Konrad JL, Seymour CW, et al. Diagnosing sepsis is subjective and highly variable: a survey of intensivists. Intensive Care Med. 2016;42:1233-1235.

Cavaillon JM, Singer M, Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med. 2020;12:e10128.

Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14:R15.

Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.

Ljungström L, Pernestig AK, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein and lactate in patients with suspected bacterial sepsis. PLoS One. 2017;12(7):e0181704.

Russell JA. The current understanding of septic shock and multiorgan dysfunction syndrome. Crit Care Clin. 2006;22(2):353-374.

Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862-874.

Venet F, Monneret G. Advances in the understanding of immune paralysis in sepsis. Front Immunol. 2018;9:2992.

Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P. Immunotherapy for the adjunctive treatment of sepsis. Am J Respir Crit Care Med. 2013;187(12):1287-1293.

Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75-87.

Wang X, Li ZY, Zeng L, Zhang AQ, Pan W, Gu W, et al. Neutrophil-to-lymphocyte ratio as a predictor of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care. 2019;23:259.

Qin B, Ma N, Tang Q, Wei X, Yang M, Fu H, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in the diagnosis of sepsis and their prognostic value. Medicine (Baltimore). 2019;98(12):e14655.

-rasm: Endothelial dysfunction and immunothrombosis in sepsis. https://pmc.ncbi.nlm.nih.gov/articles/PMC10110956/

-rasm: Sepsis: network pathophysiology and implications for early diagnosis. https://pmc.ncbi.nlm.nih.gov/articles/PMC10085556/

-rasm: Sepsis: network pathophysiology and implications for early diagnosis. https://pmc.ncbi.nlm.nih.gov/articles/PMC10085556/

Downloads

Published

2026-09-30